Skip to main content

Peer Review reports

From: The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells

Original Submission
2 Apr 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
31 May 2022 Reviewed Reviewer Report
17 Jul 2022 Reviewed Reviewer Report
3 Aug 2022 Author responded Author comments - Elias Georges
Resubmission - Version 3
3 Aug 2022 Submitted Manuscript version 3
12 Aug 2022 Author responded Author comments - Elias Georges
Resubmission - Version 4
12 Aug 2022 Submitted Manuscript version 4
18 Dec 2022 Author responded Author comments - Elias Georges
Resubmission - Version 5
18 Dec 2022 Submitted Manuscript version 5
20 Dec 2022 Reviewed Reviewer Report
21 Dec 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
22 Dec 2022 Editorially accepted
6 Jan 2023 Article published 10.1186/s12885-022-10474-x

You can find further information about peer review here.

Back to article page